Alpha Healthcare Acquisition Corp. III
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ALPAU research report →
Price Chart
About the company
Alpha Healthcare Acquisition Corp. III is not currently engaged in significant business operations. Its primary goal is to complete a strategic business combination, which may include a merger, capital stock exchange, asset acquisition, or corporate reorganization, involving one or more entities.
- CEO
- Rajiv Sarman Shukla
- IPO
- 2021
- HQ
- New York City, NY, US
Get TickerSpark's AI analysis on ALPAU
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $157.30M
- P/E
- -2.08
- PEG
- 0.02
- P/S
- 114.87
- P/B
- -2.79
- EV/EBITDA
- -47.90
- Div Yield
- 0.00%
- Gross Margin
- 58.98%
- Op Margin
- -343.58%
- Net Margin
- -404.84%
- ROE
- 107.36%
- ROIC
- 68.67%
Latest fiscal year · YoY change
- Revenue
- $1.91M+0.0%
- Gross Profit
- $1.09M+0.0%
- Op Income
- $-7,107,573
- Net Income
- $-6,905,282-427.8%
- EPS
- $-4.83-7615.7%
- OCF Growth
- +24.1%
- FCF Growth
- +23.8%
- 52W High
- $11.84
- 52W Low
- $9.44
- 50D MA
- $10.22
- 200D MA
- $10.07
- Beta
- 0.00
- RSI (14)
- 43
- Avg Volume
- 428
No earnings-call transcripts are available for ALPAU yet.
- Free Float
- 71.0%
- Shares Outstanding
- 16.13M
- Float Shares
- 11.45M
of shares held by institutions
6 13F filers
Buy/sell ratio 55.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Dec 14, 23 | Cassaday Bryan J. | buy | 440 |
| Dec 15, 23 | Spenlehauer Gilles | buy | 591 |
| Dec 14, 23 | Spenlehauer Gilles | buy | 313 |
| Dec 15, 23 | Frisch Scott M. | buy | 591 |
| Dec 14, 23 | Frisch Scott M. | buy | 313 |
| Dec 15, 23 | Sturgeon Patrick A | buy | 739 |
| Dec 14, 23 | Sturgeon Patrick A | buy | 391 |
| Sep 23, 21 | Gregory Kathryn | other | 0 |
| Dec 15, 23 | Gregory Kathryn | buy | 739 |
| Dec 14, 23 | Gregory Kathryn | buy | 391 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our ALPAU coverage
Recent articles, reports, and earnings notes.
No research on ALPAU yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ALPAU report →